Researchers have completed a clinical trial suggesting that the antidepressant drug fluvoxamine may help prevent deterioration in COVID-19 patients, making hospitalization less likely.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/11/201112113127.htm
No comments:
Post a Comment